Otsuka Holdings
4578.T
#776
Rank
โ‚น2.277 T
Marketcap
โ‚น4,240
Share price
-0.35%
Change (1 day)
27.08%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Earnings for Otsuka Holdings (4578.T)

Earnings in 2024 (TTM): โ‚น81.50 Billion

According to Otsuka Holdings 's latest financial reports the company's current earnings are โ‚น14.47 Billion. In 2023 the company made an earning of โ‚น91.67 Billion a decrease over its 2022 earnings that were of โ‚น115.78 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Otsuka Holdings from 2010 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) โ‚น81.50 B-11.09%
2023 โ‚น91.67 B-20.82%
2022 โ‚น115.78 B-13.04%
2021 โ‚น133.15 B-19.69%
2020 โ‚น165.80 B13.78%
2019 โ‚น145.72 B52.13%
2018 โ‚น95.79 B11.32%
2017 โ‚น86.05 B-36.26%
2016 โ‚น135.01 B31.64%
2015 โ‚น102.56 B
2013 โ‚น213.41 B33.73%
2012 โ‚น159.58 B-4.78%
2011 โ‚น167.59 B46.23%
2010 โ‚น114.60 B